Scientists discover potential nasal COVID-19 vaccine candidate that offers better and longer protection

A team of scientists, led by Duke-NUS Medical School, has discovered a potential intranasal vaccine candidate that provides improved, longer-lasting immunity against SARS-CoV-2 viruses compared to when given as an injection. By triggering an immune response directly at the point of entry, the intranasal vaccine candidate enhanced long-term immune memory of the virus, which could translate to a reduced need for booster shots.

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart